Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series. Cadranel J, Liu SV, Duruisseaux M, Branden E, et al. Oncologist 2021;26:7-16.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cadranel J, Liu SV, Duruisseaux M, Branden E, et al. Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series. Oncologist 2021;26:7-16.
PMID: 32852072